查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1775400

全球显影剂市场：未来预测（2025-2030）

Global Contrast Media Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 162 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

显影剂市场预计将从 2025 年的 63.09 亿美元成长到 2030 年的 89.31 亿美元，复合年增长率为 7.20%。

《显影剂市场报告》对显影剂产业进行了全面分析，为行业专业人士提供有关市场动态、技术进步和竞争策略的关键见解。本研究报告探讨了显影剂的全球格局，造影剂对于增强X光、 电脑断层扫描、MRI和超音波检查等诊断影像程序至关重要。透过探索市场区隔、市场驱动因素、市场限制和市场机会，报告为相关人员提供了可操作的信息，帮助他们在这个不断发展的领域中探索方向。

市场概况和范围

显影剂市场分析将显影剂定义为用于医学影像诊断，以提高特定器官、组织和血管可见度的物质。报告涵盖显影剂类型（碘基、钡基、钆基、生理食盐水食盐水）、给药途径（口服、灌肠、静脉/动脉内）、治疗方式（X光、CT、MRI、超音波）、应用领域（循环系统、神经系统、胃肠道、肾臟疾病、肿瘤科）以及最终用户（医院、诊所、诊断中心）。报告涵盖北美、欧洲、亚太、南美、中东和非洲等主要地区，提供按地区分類的市场趋势详细分析。

商业和技术格局

显影剂市场分析的商业前景部分指出了关键的市场驱动因素，例如慢性病盛行率上升和影像技术的进步，以及市场限制因素，例如显影剂的潜在副作用。机会包括对微创诊断日益增长的需求，以及更安全、更有效的显影剂的技术创新。波特五力分析和产业价值链分析提供了对竞争压力和供应链动态的洞察。技术前景部分重点介绍了将塑造市场未来的新兴趋势，例如低渗透压显影剂和人工智慧整合成像解决方案的发展。

竞争格局与分析

在竞争格局和分析部分，显影剂市场分析评估了主要企业的策略、市场占有率动态和最新发展。值得注意的进展包括拜耳公司推出的新一代碘基显影剂，旨在降低肾毒性风险并提高 CT 影像中的病患安全性。这项创新反映了拜耳为解决监管机构对显影剂副作用的担忧所做的努力。同样，通用电气医疗集团推出了一种针对 MRI 检查优化的新型钆基显影剂，可提高稳定性并减少体内滞留。这些发展支持产业转向以患者为中心的创新。该部分还研究了合併、收购和联盟，包括 Guerbet 与一家领先的 AI 诊断公司的策略合作伙伴关係，以整合机器学习，从而提高显影剂在诊断成像中的表现。市场占有率分析和竞争仪表板清楚地显示了 Bracco Imaging SpA、Lantheus Medical Imaging, Inc. 和 Daiichi Sankyo 等公司在这个充满活力的市场中的定位。

市场区隔与应用

该报告根据介质类型、给药途径、模式、应用和最终用户对市场进行了细分。碘基显影剂因其在电脑断层扫描中的广泛应用而占据主导地位，而钆基显影剂在MRI应用中也发挥重要作用。心血管和神经系统疾病的增加推动了对特种显影剂的需求，医院和诊断中心是主要的最终用户。按地区划分，北美凭藉其先进的医疗基础设施引领市场，而亚太地区则因中国和印度等国家诊断成像技术的日益普及而经历了快速增长。

策略和监管洞察

显影剂市场研究为相关人员提供策略建议，重点关注对更安全显影剂研发的投资以及向新兴市场的扩张。研究还探讨了影响产品开发和上市策略的政策和政策，例如美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 关于显影剂安全性的严格指南。这些见解对于寻求满足监管标准并把握市场机会的行业专业人士至关重要。

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要企业采取的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 适用范围广：对于新兴企业、研究机构、顾问公司、中小企业和大型企业来说，它都是实用且具有成本效益的。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章全球显影剂市场（依显影剂类型）

  • 介绍
  • 碘基
  • 钡基
  • 钆基
  • 生理食盐水

6. 全球显影剂市场（依管理途径）

  • 介绍
  • 口服
  • 灌肠剂
  • 静脉/动脉

7. 全球显影剂市场（按方式）

  • 介绍
  • X射线
  • 电脑断层扫描（CT）
  • 磁振造影（MRI）
  • 超音波

第八章全球显影剂市场（按应用）

  • 介绍
  • 循环系统疾病
  • 神经系统疾病
  • 胃肠道疾病
  • 肾臟疾病
  • 癌症

9. 全球显影剂市场（按最终用户）

  • 介绍
  • 医院和诊所
  • 诊断中心

第 10 章全球显影剂市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十一章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 企业合併、协议、商业合作
  • 竞争仪錶板

第十二章 公司简介

  • Bayer AG
  • Bracco Imaging SpA
  • GE HealthCare
  • Guerbet
  • Lantheus Medical Imaging, Inc.
  • Daiichi Sankyo Company
  • Jodas Expoim
  • Nano Therapeutics Pvt. Ltd.

第十三章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613767

The Global Contrast Media Market is expected to grow from USD 6.309 billion in 2025 to USD 8.931 billion in 2030, at a CAGR of 7.20%.

The Global Contrast Media Market Study provides a comprehensive analysis of the contrast media industry, offering industry experts critical insights into market dynamics, technological advancements, and competitive strategies. This study examines the global landscape of contrast media, essential for enhancing diagnostic imaging procedures such as X-rays, CT scans, MRIs, and ultrasounds. By exploring market segmentation, drivers, restraints, and opportunities, the study equips stakeholders with actionable intelligence to navigate this evolving sector.

Market Overview and Scope

The Global Contrast Media Market Study defines contrast media as substances used to improve the visibility of specific organs, tissues, or blood vessels during medical imaging. The scope encompasses various media types (iodine-based, barium-based, gadolinium, and saline), administration routes (oral, enema, intravenous/intra-arterial), modalities (X-rays, CT, MRI, ultrasound), applications (cardiovascular, neurological, gastrointestinal, nephrology disorders, and cancer), and end-users (hospitals, clinics, and diagnostic centers). The study covers key geographic regions, including North America, Europe, Asia Pacific, South America, and the Middle East and Africa, providing a granular view of regional market trends.

Business and Technological Landscape

The business landscape section of the Global Contrast Media Market Study identifies key market drivers, such as the rising prevalence of chronic diseases and advancements in imaging technologies, alongside restraints like potential side effects of contrast agents. Opportunities include the growing demand for minimally invasive diagnostics and innovations in safer, more effective contrast media. A Porter's Five Forces analysis and industry value chain analysis offer insights into competitive pressures and supply chain dynamics. The technological outlook highlights emerging trends, such as the development of low-osmolar contrast agents and AI-integrated imaging solutions, shaping the future of the market.

Competitive Environment and Analysis

In the competitive environment and analysis section, the Global Contrast Media Market Study evaluates the strategies of major players, market share dynamics, and recent developments. Notable advancements include Bayer AG's launch of a next-generation iodine-based contrast agent designed to reduce nephrotoxicity risks, enhancing patient safety in CT imaging. This innovation reflects Bayer's focus on addressing regulatory concerns about contrast media side effects. Similarly, GE HealthCare has introduced a novel gadolinium-based contrast agent optimized for MRI scans, offering improved stability and reduced retention in the body, aligning with growing demand for safer diagnostic solutions. These developments underscore the industry's shift toward patient-centric innovations. The section also explores mergers, acquisitions, and collaborations, such as Guerbet's strategic partnership with a leading AI diagnostics firm to integrate machine learning for enhanced contrast media performance in imaging. Market share analysis and a competitive dashboard provide a clear picture of how players like Bracco Imaging S.p.A., Lantheus Medical Imaging, Inc., and Daiichi Sankyo Company are positioning themselves in this dynamic market.

Market Segmentation and Applications

The study segments the market by media type, administration route, modality, application, and end-user. Iodine-based contrast media dominate due to their widespread use in CT scans, while gadolinium-based agents are critical for MRI applications. The rise in cardiovascular and neurological disorders drives demand for specialized contrast media, with hospitals and diagnostic centers as primary end-users. Regionally, North America leads due to advanced healthcare infrastructure, while Asia Pacific shows rapid growth driven by increasing diagnostic imaging adoption in countries like China and India.

Strategic and Regulatory Insights

The Global Contrast Media Market Study provides strategic recommendations for stakeholders, emphasizing investment in R&D for safer contrast agents and expansion into emerging markets. The study also examines policies and regulations, such as stringent FDA and EMA guidelines on contrast media safety, which influence product development and market entry strategies. These insights are critical for industry experts aiming to align with regulatory standards and capitalize on market opportunities.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Contrast Media Market Segmentation:

By Media Type

  • Iodine-based
  • Barium-based
  • Gadolinium
  • Saline

By Administration Route

  • Oral
  • Enema
  • Intravenously/Intra arterially

By Modality

  • X-Rays
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound

By Application

  • Cardiovascular disorders
  • Neurological disorders
  • Gastrointestinal disorders
  • Nephrology disorders
  • Cancer

By End-User

  • Hospitals and Clinics
  • Diagnostic Centres

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Australia
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CONTRAST MEDIA MARKET BY MEDIA TYPE

  • 5.1. Introduction
  • 5.2. Iodine-based
  • 5.3. Barium-based
  • 5.4. Gadolinium
  • 5.5. Saline

6. GLOBAL CONTRAST MEDIA MARKET BY ADMINISTRATION ROUTE

  • 6.1. Introduction
  • 6.2. Oral
  • 6.3. Enema
  • 6.4. Intravenously/Intraraterially

7. GLOBAL CONTRAST MEDIA MARKET BY MODALITY

  • 7.1. Introduction
  • 7.2. X-Rays
  • 7.3. Computed Tomography (CT)
  • 7.4. Magnetic Resonance Imaging (MRI)
  • 7.5. Ultrasound

8. GLOBAL CONTRAST MEDIA MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Cardiovascular disorders
  • 8.3. Neurological disorders
  • 8.4. Gastrointestinal disorders
  • 8.5. Nephrology disorders
  • 8.6. Cancer

9.. GLOBAL CONTRAST MEDIA MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Hospitals and Clinics
  • 9.3. Diagnostic Centres

10. GLOBAL CONTRAST MEDIA MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. USA
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2 Argentina
    • 10.3.3. Others
  • 10.4. Europe
    • 10.4.1. Germany
    • 10.4.2. France
    • 10.4.3. United Kingdom
    • 10.4.4. Spain
    • 10.4.5. Others
  • 10.5. Middle East and Africa
    • 10.5.1. Saudi Arabia
    • 10.5.2. UAE
    • 10.5.3. Others
  • 10.6. Asia Pacific
    • 10.6.1. China
    • 10.6.2. India
    • 10.6.3. Japan
    • 10.6.4. South Korea
    • 10.6.5. Indonesia
    • 10.6.6. Thailand
    • 10.6.7. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. Bayer AG
  • 12.2. Bracco Imaging S.p.A.
  • 12.3. GE HealthCare
  • 12.4. Guerbet
  • 12.5. Lantheus Medical Imaging, Inc.
  • 12.6. Daiichi Sankyo Company
  • 12.7. Jodas Expoim
  • 12.8. Nano Therapeutics Pvt. Ltd.

13. APPENDIX

  • 13.1. Currency
  • 13.2. Assumptions
  • 13.3. Base and Forecast Years Timeline
  • 13.4. Key benefits for the stakeholders
  • 13.5. Research Methodology
  • 13.6. Abbreviations